Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Journal of Cancer Research and Clinical Oncology

Issue 10/2025

Content (21 Articles)

Development of a predictive model for distant metastasis in HCC patients post-TACE using clinical data, radiomics, and deep learning

Chenglong Liu, Long Han, Xiang Ding, Junshan Hao, Peng Yang, Ying Wang, Weifu Zhang, Zhe Yang

PPARγ accelerates OSCC progression via Th17 polarization and CEBPA/IL-17C signaling

  • Open Access
  • Research

Ying Wang, Jing Liang, Shiyu Zhang, Yingxin Zhang, Fangbu Cheng, Ning Ji, Jing Li, Qianming Chen, Xin Zeng

Correction: Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic review

Roberto Rosenfeld, Stefano Sganga, Marco Badalamenti, Sveva Mortellaro, Marta Scorsetti, Ornella Garrone, Giovanni Maria Iannantuono, Elias Chandran, Michele Ghidini, Ciro Franzese

Multimodal radiomics fusion for predicting postoperative recurrence in NSCLC patients

Ghazal Mehri-kakavand, Sibusiso Mdletshe, Mehdi Amini, Alan Wang

MiR-26b-5p mediates radioresistance and immunosuppression via targeting PRKCD in non-small cell lung cancer

  • Open Access
  • NSCLC
  • Research

Xu Chen, Rui Kong, Yaxian Qi, Lingchen Li, Chenrui Yin, Lingyou Sun, Chunli Jian, Ping Cai, Qiao Yang, Jianguo Sun

Advancing our understanding of the influence of myeloid-derived suppressor cells in chronic myeloid leukemia

Xing Meng, Yue Zhang, Hong Xu, Yanyan Zhang, Hao He, Jianmin Ma, Xiaoyan Zhang

Low expression of HSP27 and HSP70 predicts poor prognosis in laryngeal squamous cell carcinoma

Jędrzej Borowczak, Dariusz Łaszczych, Adrianna Czyżnikiewicz, Andrzej Marszałek, Łukasz Szylberg, Magdalena Bodnar

Advancements in the diagnosis and management of capecitabine-induced hand-foot syndrome

Baohua Chen, Xingyu Wang, Lingjun Meng

Effect of gamma knife dose rate and tumor-specific factors on treatment outcomes in brain metastases: insights from a cohort study

Onur Erdoğan, Alaattin Fidan, Mustafa Sakar, Beste M. Atasoy

PDGFC facilitates enzalutamide resistance in prostate cancer through activation of the Rap1-MAPK pathway

Bingqian Deng, Saipeng Chen, Dan Zhong, Guojing Song, Heting Liu, Langlang Xie, Youxin Liu, Rongrong Ni, Wenhao Shen, Gang Huang

Prediction models for different types of leukemia: a systematic review and critical appraisal

Ayizhati Tuerxun, Yingzi Yang, Xinqi Cai, Xinyu Chen, Zhuoya Zhao, Yang Zhao, Zinuo Lin, Shengfeng Wang

Casein kinase 1 family member CSNK1E can regulate proliferation and migration in hepatocellular carcinoma

Jie Zhou, Yu-Hui Wang, Yong-Le Li, Xiao-Mei Xie, Zhou Jiang, Xin Zhuo, Xu-dong Shan, Shu-Tin Cheng, Li-He Jiang

Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-negative breast cancer

Nurullah İlhan, Süleyman Baş, Onur Alkan, Akif Doğan, Nargiz Majidova, Mustafa Alperen Tunç, Engin Erdemoğlu, Buğra Öztosun, İlker Nihat Ökten, Mahmut Gümüş

Real-world evidence on the additional cancer risk reduction of ezetimibe: a 10-year nationwide retrospective cohort study emulating a target trial

Yohwan Lim, Eunji Kim, Eunjung Hwang, Koanhoi Kim, Yonghae Son, Sang Yeoup Lee, Young Hye Cho, Eun-Ju Park, Youngin Lee, Sae Rom Lee, Jung-In Choi, Han-Sol Jeong, Su-Jung Park, Soo Min Son, Ryuk Jun Kwon

Retrospective analysis of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia: focus on rechallenge with pegaspargase

Chenhong Jia, Qian Li, Xiaoying Zhai, Meijie Quan, Bing Bai, Xiangyu Ding

Pellino ubiquitin ligases: double-edged swords in hematologic malignancies–from oncogenic stabilizers to therapeutic vulnerabilities

  • Open Access
  • Review

Mingfeng Yang, Ya Li, Jianhong Wang

Artificial neural networks as a prognostic tool using hyperspectral imaging on pretherapeutic histopathological specimens of esophageal adenocarcinoma

  • Open Access
  • Research

Christel Teresa Trifone, Marianne Maktabi, Philipp Bischoff, Katrin Schierle, Stefan Niebisch, Yusef Moulla, Patrick Sven Plum, Boris Jansen-Winkeln, Ines Gockel, René Thieme

Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study

Maryann Kwa, Grant Hussey, Yelena Novik, Adrian A. Franke, Angelina Volkova, Karina Flores, Martin J. Blaser, James Speyer, Ruth Oratz, Marleen Meyers, Komal Jhaveri, Ezeddin Fadel, Adriana Heguy, Jonas Schluter, Kelly V. Ruggles, Sylvia Adams

tRF-34-86J8WPMN1E8Y2Q promotes the occurrence and development of gastric cancer by combining with LRAT

Chunli Cao, Shengli Xu, Zhe Li

Mapping the global clinical landscape of NK cell therapies for solid tumors: an analysis based on the ClinicalTrials.gov for the 2005–2024 period

Wenjuan Wei, Ximeng Wu, Lizhi Wang, Jianing Zhang, Chan Zhang, Daqing Wang

EYA1 promotes tumor angiogenesis in colorectal cancer by activating HIF-1β through LSD2-mediated H3K4me2 demethylation

Shaoxin Cai, Jiansheng Wu, Naisen Wang, Chengchuan Zheng, Jianglin Su, Changqing Zeng, Jinsi Wang

Sep 25
Issue: 9/2025
Nov 25
Issue: 11/2025

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on progress in colorectal cancer

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Prof. Antoni Castells
Prof. Harpreet Wasan
Prof. Edward Giovannucci
Watch now
Image Credits
Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images